[{"id":"24ecc665-dd64-4425-8972-8b5aa267e94d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01051063","created_at":"2021-01-18T04:07:55.854Z","updated_at":"2024-07-02T16:37:05.020Z","phase":"Phase 1","brief_title":"Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy","source_id_and_acronym":"NCT01051063","lead_sponsor":"GlaxoSmithKline","biomarkers":" WT1","pipe":"","alterations":" ","tags":["WT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GSK2130579A"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 12/09/2009","start_date":" 12/09/2009","primary_txt":" Primary completion: 04/26/2016","primary_completion_date":" 04/26/2016","study_txt":" Completion: 04/26/2016","study_completion_date":" 04/26/2016","last_update_posted":"2018-11-29"},{"id":"5a9cc975-6902-4148-8104-c6db0e87177c","acronym":"","url":"https://clinicaltrials.gov/study/NCT00725283","created_at":"2021-02-01T11:52:15.287Z","updated_at":"2024-07-02T16:37:08.186Z","phase":"Phase 1","brief_title":"Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)","source_id_and_acronym":"NCT00725283","lead_sponsor":"GlaxoSmithKline","biomarkers":" WT1","pipe":"","alterations":" ","tags":["WT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GSK2130579A"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 10/01/2008","start_date":" 10/01/2008","primary_txt":" Primary completion: 06/22/2016","primary_completion_date":" 06/22/2016","study_txt":" Completion: 06/22/2016","study_completion_date":" 06/22/2016","last_update_posted":"2018-08-07"}]